256 related articles for article (PubMed ID: 16899113)
1. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Song CQ; Li Y; Mou H; Moore J; Park A; Pomyen Y; Hough S; Kennedy Z; Fischer A; Yin H; Anderson DG; Conte D; Zender L; Wang XW; Thorgeirsson S; Weng Z; Xue W
Gastroenterology; 2017 Apr; 152(5):1161-1173.e1. PubMed ID: 27956228
[TBL] [Abstract][Full Text] [Related]
3. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
Hong SK; Yoon S; Moelling C; Arthan D; Park JI
J Biol Chem; 2009 Nov; 284(48):33006-18. PubMed ID: 19805545
[TBL] [Abstract][Full Text] [Related]
4. Sensing and integration of Erk and PI3K signals by Myc.
Lee T; Yao G; Nevins J; You L
PLoS Comput Biol; 2008 Feb; 4(2):e1000013. PubMed ID: 18463697
[TBL] [Abstract][Full Text] [Related]
5. Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation.
Fedorov YV; Jones NC; Olwin BB
Mol Cell Biol; 2002 Feb; 22(4):1140-9. PubMed ID: 11809805
[TBL] [Abstract][Full Text] [Related]
6. Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.
Hensch NR; Bondra K; Wang L; Sreenivas P; Zhao XR; Modi P; Vaseva AV; Houghton PJ; Ignatius MS
Mol Cancer Ther; 2023 Jan; 22(1):123-134. PubMed ID: 36162055
[TBL] [Abstract][Full Text] [Related]
7. New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.
Gottfried E; Lang SA; Renner K; Bosserhoff A; Gronwald W; Rehli M; Einhell S; Gedig I; Singer K; Seilbeck A; Mackensen A; Grauer O; Hau P; Dettmer K; Andreesen R; Oefner PJ; Kreutz M
PLoS One; 2013; 8(7):e66987. PubMed ID: 23874405
[TBL] [Abstract][Full Text] [Related]
8. TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway.
Tian Y; Xin S; Wan Z; Dong H; Liu L; Fan Z; Li T; Peng F; Xiong Y; Han Y
Transl Oncol; 2024 May; 45():101978. PubMed ID: 38701650
[TBL] [Abstract][Full Text] [Related]
9. Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy.
Chen W; Mou KY; Solomon P; Aggarwal R; Leung KK; Wells JA
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33483421
[TBL] [Abstract][Full Text] [Related]
10. Calothrixin B derivatives induce apoptosis and cell cycle arrest on HEL cells through the ERK/Ras/Raf/MEK pathway.
Wang B; Wang M; Li K; Wang C; Liu X; Rao Q; Song J; Hang Y; Liu S; Wen M; Huang L; Li Y
Biomed Pharmacother; 2024 Feb; 171():116179. PubMed ID: 38278023
[TBL] [Abstract][Full Text] [Related]
11. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells.
Park YR; Jee W; Park SM; Kim SW; Jung JH; Kim H; Kim KI; Jang HJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139419
[TBL] [Abstract][Full Text] [Related]
12. TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis.
Shi H; Ju Q; Mao Y; Wang Y; Ding J; Liu X; Tang X; Sun C
Adv Sci (Weinh); 2021 Mar; 8(5):2001575. PubMed ID: 33717835
[TBL] [Abstract][Full Text] [Related]
13. Spots and stripes: pleomorphic patterning of stem cells via p-ERK-dependent cell chemotaxis shown by feather morphogenesis and mathematical simulation.
Lin CM; Jiang TX; Baker RE; Maini PK; Widelitz RB; Chuong CM
Dev Biol; 2009 Oct; 334(2):369-82. PubMed ID: 19647731
[TBL] [Abstract][Full Text] [Related]
14. Tilting MYC toward cancer cell death.
Harrington CT; Sotillo E; Dang CV; Thomas-Tikhonenko A
Trends Cancer; 2021 Nov; 7(11):982-994. PubMed ID: 34481764
[TBL] [Abstract][Full Text] [Related]
15. Pathway-Directed Therapy in Multiple Myeloma.
John L; Krauth MT; Podar K; Raab MS
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916289
[TBL] [Abstract][Full Text] [Related]
16. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.
Li M; Zhang CL; Zhou DS; Chan SH; Liu XQ; Chen SN; Yang ZY; Ju FE; Sang XY; Liu ZX; Zhang QX; Pan YM; Deng SS; Wang XM; Zhong L; Zhang XD; Du X
Br J Haematol; 2024 Apr; 204(4):1307-1324. PubMed ID: 38462771
[TBL] [Abstract][Full Text] [Related]
17. Anchorage-independent cell growth signature identifies tumors with metastatic potential.
Mori S; Chang JT; Andrechek ER; Matsumura N; Baba T; Yao G; Kim JW; Gatza M; Murphy S; Nevins JR
Oncogene; 2009 Aug; 28(31):2796-805. PubMed ID: 19483725
[TBL] [Abstract][Full Text] [Related]
18. Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest.
Kubickova A; De Sanctis JB; Hajduch M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139353
[TBL] [Abstract][Full Text] [Related]
19. Vitamin B
Kreuzaler P; Inglese P; Ghanate A; Gjelaj E; Wu V; Panina Y; Mendez-Lucas A; MacLachlan C; Patani N; Hubert CB; Huang H; Greenidge G; Rueda OM; Taylor AJ; Karali E; Kazanc E; Spicer A; Dexter A; Lin W; Thompson D; Silva Dos Santos M; Calvani E; Legrave N; Ellis JK; Greenwood W; Green M; Nye E; Still E; ; Barry S; Goodwin RJA; Bruna A; Caldas C; MacRae J; de Carvalho LPS; Poulogiannis G; McMahon G; Takats Z; Bunch J; Yuneva M
Nat Metab; 2023 Nov; 5(11):1870-1886. PubMed ID: 37946084
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of aminopyridine containing biaryls reducing c-MYC protein levels in cells.
Di Marco CN; Terrell L; Sanchez R; Rueda L; Shuster L; Nartey EN; McHugh C; Mack JF; Shu A; Tian X; Medina JR; Rivero R; Manetsch R; Heerding D; Mangatt B
Bioorg Med Chem Lett; 2023 Aug; 92():129385. PubMed ID: 37339719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
